Critical & Chronic Care >
I.V. Site Dressings > 3M™ Tegaderm™ CHG Chlorhexidine Gluconate IV Securement Dressing 1658
3M™ Tegaderm™ CHG Chlorhexidine Gluconate IV Securement Dressing 1658
3M ID
70200764036
UPC#
50707387578324
3M Product Number
1658
CAT#
1658
4 inch x 4-3/4 inch (10cm x 12cm) CHG Chlorhexidine Gluconate IV Securement Dressing
Benefits
Proven to be as effective as, or better at, reducing skin flora on healthy volunteers for up to 10 days than BIOPATCH{1}
Proven to be more effective at preventing re-growth on healthy volunteers at 7 days than BIOPATCH{1}
Transparent, allowing continuous visualization of insertion site
Integrated design of dressing and CHG gel pad reduces application steps and minimizes potential for application error
As easy-to-use and easy-to-train as a Tegaderm™ dressing
Large surface area to provide coverage of catheter and suture sites
Absorbs fluid
Larger coverage area than BIOPATCH{1} allows for coverage of sutures as well as insertion site
{1} - Trademark ETHICON, INC.
Suggested Applications
Non-tunneled central venous catheters (CVC)
Pheripherally Inserted Central Catheters (PICCs)
Tunneled CVCs
Arterial catheters
Dialysis catheters
Midline catheters
Any percutaneous device
Specifications
Brand
Tegaderm
Condition
I.V. Related
Department
Cardiovascular, Dialysis Center, Emergency, I.V. Therapy, Intensive Care Unit, Medical-Surgical, Oncology, Operating Room-Surgery, Pediatrics, Radiology, Urgent Care, Wound Care
Dressing Type
Film Dressing
IV Related Condition Type
Arterial Catheter, CVC Dialysis, CVC Implanted Port, CVC PICC, CVC Short-term, CVC Tunneled, Epidural Catheter, PIV
Latex
No
Product Type
Antimicrobial Dressing
Clinicals
Use of CHG on Central Line Insertion Sites, pdf
(PDF, 103.7KB)
Tegaderm CHG Gel Dressing Absorption - Poster - Lo Res - English
(PDF, 978.5KB)
Study of Bloodstream Infection Rates
(PDF, 448.0KB)
Novel Integrated Chlorhexidine-impregnated Dressing, Dr. Maki
(PDF, 1.3MB)
Migration of Chlorhexidine Gluconate Clinical
(PDF, 162.6KB)
Tegaderm CHG Drsg: Park Nicollet Methodist Hospital Evaluation
(PDF, 608.5KB)
Tegaderm CHG IV Growth Inhibitions of Microorganisms
(PDF, 385.5KB)
Suppression of Regrowth under CHG Drsg
(PDF, 429.9KB)
Clinical Performance of Chlorhexidine Gel Pad, Mark Rupp
(PDF, 787.9KB)
Tegaderm CHG Drsg: Antimicrobial Activity for IV Site Evaluation
(PDF, 211.4KB)
Tegaderm CHG IV Evaluation of Gel Pad Drsg
(PDF, 1.1MB)
Clinical Performance of Chlorhexidine Gluconate
(PDF, 179.9KB)
Tegaderm CHG Drsg: Multicenter Prospective Open Label Evaluation
(PDF, 2.3MB)
